Tarrytown, NY, United States of America

Cheng Wang

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignees: Intellia Therapeutics, Inc., Regeneron Pharmaceuticals, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cheng Wang. Retrieved from https://idiyas.com/inventor/cheng-wang-5889gozc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cheng Wang: Innovator in Factor IX Expression

Introduction

Cheng Wang is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the field of biotechnology, particularly in the area of gene therapy and protein expression.

Latest Patents

Cheng Wang holds a patent for "Compositions and methods for expressing Factor IX." This patent provides compositions and methods for expressing Factor IX in a host cell or a population of host cells. Additionally, it includes engineered host cells that express Factor IX, showcasing his innovative approach to addressing medical needs.

Career Highlights

Throughout his career, Cheng Wang has worked with prominent companies in the biotechnology sector. He has been associated with Intellia Therapeutics, Inc. and Regeneron Pharmaceuticals, Inc., where he has contributed to groundbreaking research and development efforts.

Collaborations

Cheng has collaborated with esteemed colleagues, including Jonathan Douglas Finn and Hon-Ren Huang, further enhancing the impact of his work in the field.

Conclusion

Cheng Wang's contributions to the expression of Factor IX and his collaborations with leading companies and professionals highlight his role as an influential inventor in biotechnology. His work continues to pave the way for advancements in gene therapy and medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…